查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869971

痔瘡治療市場規模、佔有率和趨勢分析報告：按疾病、藥物類別、分銷管道、地區和細分市場預測（2025-2033 年）

Hemorrhoids Treatment Market Size, Share & Trends Analysis Report By Disease (Internal Hemorrhoids, External Hemorrhoids), By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

痔瘡治療中心摘要

2024年全球痔瘡治療市場規模估計為7.6299億美元，預計2033年將達到14.6528億美元。

預計從 2025 年到 2033 年，該市場將以 7.5% 的複合年成長率成長。市場成長的促進因素是痔瘡盛行率的上升，而痔瘡盛行率上升的原因是久坐不動的生活方式、不良的飲食習慣、肥胖症的增加以及人口老化導致組織彈性下降等因素。

例如，根據2024年12月《疾病與全球健康雜誌》的一篇文章，全球50%至85%的人口一生中會患痔瘡，其中四分之一的非洲50歲以上人群受其影響。同一項研究報告稱，在美國，因痔瘡就診的門診患者達330萬人次，使其成為門診就診的第四大常見胃腸道疾病。輕度至中度痔瘡可透過攝取纖維、補充水分和坐浴進行治療，而重度痔瘡則需採用橡皮筋結紮術、硬化療法和紅外線凝固術。晚期痔瘡則需要進行痔瘡釘合術或動脈結紮術，術後護理包括控制疼痛、出血和閉尿症。人們對痔瘡的認知不斷提高，診斷技術的進步也推動了及時介入和治療需求的成長。

痔瘡治療技術的創新正在改變患者照護，並推動市場擴張。微創手術，如橡皮筋結紮術、紅外線凝固術和雷射療法，因其縮短恢復時間、減輕疼痛和減少併發症而吸引了更多患者。先進的局部用藥和口服藥物能夠改善症狀控制並提高患者依從性，而創新的聯合療法則能從多個方面治療疾病。例如，根據2024年6月發表在《韓國生物醫學評論》上的一篇文章，全球超過80%的人口一生中都會患上痔瘡，其中45至65歲人群的患病率超過50%。該報導強調了早期診斷、制定合適的治療策略以及調整生活方式（包括飲食改善和增加運動）對於控制和預防併發症的重要性。診所和醫院正擴大採用這些手術方法，以最佳化治療效果和效率，並減少住院時間和術後追蹤的需求。治療方式和治療技術的不斷改進，促進了這些療法的更廣泛應用，推動了它們在全球已開發市場和新興市場的成長。

消費者對便利、有效且易於取得的痔瘡治療方法的需求正在推動市場進一步成長。非處方藥膏、栓劑和口服補充劑為患者提供了在家中自我護理的實用選擇，同時，意識提升也鼓勵他們積極主動地管理症狀。行銷宣傳活動、宣傳活動和數位平台突顯了現代治療方法的益處和易用性，從而提高了患者的參與度。不斷拓展的通路，包括藥局、專科診所和電商平台，確保了更廣泛的供應和便利性。隨著患者越來越傾向於安全、微創且可在家中進行的治療方案，製造商和醫療機構不斷創新，推出新產品和治療方案，以滿足不斷變化的消費者期望和需求。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 痔瘡治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 定價分析

第4章 痔瘡治療市場：依疾病分類的商業分析

  • 疾病市場佔有率，2024 年和 2033 年
  • 疾病細分儀表板
  • 市場規模與預測、疾病特定趨勢分析，2021-2033年
  • 內痔
  • 外痔
  • 混合型痔瘡

第5章 痔瘡治療市場：依藥物類別分類的業務分析

  • 2024 年及 2033 年各藥物類別市佔率
  • 藥物類別細分儀表板
  • 按藥物類別分類的市場規模、預測和趨勢分析，2021-2033年
  • 皮質類固醇
  • 局部麻醉劑
  • 血管收縮劑
  • 其他

第6章 痔瘡治療市場：依分銷管道分類的業務分析

  • 2024 年及 2033 年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 按分銷管道分類的市場規模、預測和趨勢分析，2021-2033年
  • 網路藥房
  • 零售藥房
  • 醫院藥房

第7章 痔瘡治療市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析（2021-2033）：
  • 北美洲
    • 按國家/地區分類，2021-2033 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介
    • Lupin
    • Cipla
    • Amato Pharmaceutical Products, Ltd.
    • Church &Dwight Co., Inc
    • Haleon Group of Companies
    • Sebela Pharmaceuticals
    • Bayer AG
    • Sanofi
    • Abbott
    • Sun Pharmaceutical Industries, Inc
Product Code: GVR-4-68040-783-7

Hemorrhoids Treatment Market Summary

The global hemorrhoids treatment market size was estimated at USD 762.99 million in 2024 and is projected to reach USD 1,465.28 million by 2033, growing at a CAGR of 7.5% from 2025 to 2033. The increasing prevalence of hemorrhoidal disorders is driving market growth, influenced by sedentary lifestyles, poor diets, rising obesity, and aging, which reduces tissue elasticity.

For instance, in December 2024, Journal of Disease and Global Health reported that 50% to 85% of the global population experienced hemorrhoids in their lifetime, with one-quarter of Africans over 50 affected. The study noted 3.3 million U.S. ambulatory-care visits, making hemorrhoids the fourth most common gastrointestinal disorder in outpatient settings. Mild to moderate cases were managed with fiber, hydration, and sitz baths, while severe cases used rubber band ligation, sclerotherapy, or infrared coagulation. Advanced cases required stapled hemorrhoidopexy or artery ligation, with postoperative care addressing pain, bleeding, and urinary retention. Greater awareness and diagnostic advances are driving timely interventions and treatment demand.

Technological innovations in hemorrhoid treatment methods are transforming patient care and supporting market expansion. Minimally invasive procedures, such as rubber band ligation, infrared coagulation, and laser therapy, offer faster recovery, reduced pain, and minimal complications, attracting more patients. Advanced topical formulations and oral medications improve symptom management and enhance patient adherence, while innovative combination therapies address multiple aspects of the disorder. For instance, in June 2024, Korea Biomedical Review reported that over 80% of the global population experiences hemorrhoids at some point, particularly individuals aged 45 to 65, with prevalence exceeding 50% in those over 50. The article emphasized early diagnosis, appropriate treatment strategies, and lifestyle modifications, including dietary changes and exercise, to manage and prevent complications. Clinics and hospitals increasingly implement these procedures to optimize outcomes and efficiency, reducing hospital stays and post-treatment follow-up requirements. Continuous improvements in treatment delivery and procedural techniques encourage wider adoption of these therapies, fostering growth across both developed and emerging markets globally.

Consumer demand for convenient, effective, and accessible hemorrhoid treatments is fueling market growth further. Over-the-counter ointments, suppositories, and oral supplements provide patients with practical options for self-care at home, while increasing awareness of lifestyle interventions encourages proactive symptom management. Marketing campaigns, educational initiatives, and digital platforms highlight the advantages and ease of use of modern treatments, enhancing patient engagement. Expanding distribution channels, including pharmacies, specialty clinics, and e-commerce platforms, ensure wider availability and accessibility. As patients increasingly prefer safe, minimally invasive, and home-based treatment solutions, manufacturers and healthcare providers continue to innovate, introducing new products and therapeutic options that meet evolving consumer expectations and needs.

Global Hemorrhoids Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hemorrhoids treatment market report based on disease, drug class, distribution channel, and region:

  • Disease Outlook (Revenue, USD Million, 2021 - 2033)
  • Internal Hemorrhoids
  • External Hemorrhoids
  • Mixed Hemorrhoids
  • Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
  • Corticosteroids
  • Local Anesthetics
  • Vasoconstrictors
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Drug Class
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hemorrhoids Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Pricing Analysis

Chapter 4. Hemorrhoids Treatment Market: Disease Business Analysis

  • 4.1. Disease Market Share, 2024 & 2033
  • 4.2. Disease Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
  • 4.4. Internal Hemorrhoids
    • 4.4.1. Internal Hemorrhoids Market, 2021 - 2033 (USD Million)
  • 4.5. External Hemorrhoids
    • 4.5.1. External Hemorrhoids Market, 2021 - 2033 (USD Million)
  • 4.6. Mixed Hemorrhoids
    • 4.6.1. Mixed Hemorrhoids Market, 2021 - 2033 (USD Million)

Chapter 5. Hemorrhoids Treatment Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2024 & 2033
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 5.4. Corticosteroids
    • 5.4.1. Corticosteroids Market, 2021 - 2033 (USD Million)
  • 5.5. Local Anesthetics
    • 5.5.1. Local Anesthetics Market, 2021 - 2033 (USD Million)
  • 5.6. Vasoconstrictors
    • 5.6.1. Vasoconstrictors Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Hemorrhoids Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2033
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Online Pharmacy
    • 6.4.1. Online Pharmacy Market, 2021 - 2033 (USD Million)
  • 6.5. Retail Pharmacy
    • 6.5.1. Retail Pharmacy Market, 2021 - 2033 (USD Million)
  • 6.6. Hospital Pharmacy
    • 6.6.1. Hospital Pharmacy Market, 2021 - 2033 (USD Million)

Chapter 7. Hemorrhoids Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Hemorrhoids Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Lupin
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Cipla
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Amato Pharmaceutical Products, Ltd.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Church & Dwight Co., Inc
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Haleon Group of Companies
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Sebela Pharmaceuticals
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Bayer AG
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Sanofi
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Abbott
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sun Pharmaceutical Industries, Inc
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global hemorrhoids treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 5. Global hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 6. Global hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7. North America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 8. North America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 9. North America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 10. North America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11. U.S. hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 12. U.S. hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 13. U.S. hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 14. Canada hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 15. Canada hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 16. Canada hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 17. Mexico hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 18. Mexico hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 19. Mexico hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20. Europe hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 21. Europe hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 22. Europe hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 23. Europe hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24. UK hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 25. UK hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 26. UK hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 27. Germany hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 28. Germany hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 29. Germany hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30. France hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 31. France hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 32. France hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 33. Italy hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 34. Italy hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 35. Italy hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 36. Spain hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 37. Spain hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 38. Spain hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39. Norway hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 40. Norway hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 41. Norway hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 42. Denmark hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 43. Denmark hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 44. Denmark hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45. Sweden hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 46. Sweden hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 47. Sweden hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 51. Asia Pacific hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD
  • Table 52. Japan hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 53. Japan hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 54. Japan hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 55. China hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 56. China hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 57. China hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 58. India hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 59. India hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 60. India hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61. Australia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 62. Australia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 63. Australia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 64. South Korea hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 65. South Korea hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 66. South Korea hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 67. Thailand hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 68. Thailand hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 69. Thailand hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70. Latin America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 71. Latin America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 72. Latin America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 73. Latin America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 74. Brazil hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 75. Brazil hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 76. Brazil hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 77. Argentina hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 78. Argentina hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 79. Argentina hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 83. Middle East & Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 84. South Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 85. South Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 86. South Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 90. UAE hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 91. UAE hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 92. UAE hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 93. Kuwait hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 94. Kuwait hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
  • Table 95. Kuwait hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Hemorrhoids treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hemorrhoids treatment market dynamics
  • Fig. 12 Hemorrhoids treatment market: Porter's five forces analysis
  • Fig. 13 Hemorrhoids treatment market: PESTLE analysis
  • Fig. 14 Disease market, 2021 - 2033 (USD Million)
  • Fig. 15 Internal Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 16 External Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 17 Mixed Hemorrhoids market, 2021 - 2033 (USD Million)
  • Fig. 18 Drug Class market, 2021 - 2033 (USD Million)
  • Fig. 19 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 20 Local Anesthetics market, 2021 - 2033 (USD Million)
  • Fig. 21 Vasoconstrictors market, 2021 - 2033 (USD Million)
  • Fig. 22 Others market, 2021 - 2033 (USD Million)
  • Fig. 23 Distribution channel market, 2021 - 2033 (USD Million)
  • Fig. 24 Online pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 25 Retail pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 26 Hospital pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 27 Hemorrhoids treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 MEA hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait hemorrhoids treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework